Молодежный инновационный вестникМолодежный инновационный вестник2415-7805Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации10027Conference ProceedingsAnticoagulant therapy in secondary stroke preventionKhmyzInna Sergeevna<p>Resident of the Department of Neurology</p>innakhmyz2012@yandex.ruhttps://orcid.org/0000-0003-1119-4798ZolotarevOleg V.<p>Docent of the Department of Neurology, Candidate of Medical Sciences</p>nerv.zolotarev@mail.ruhttps://orcid.org/0000-0002-6513-0522Voronezh State Medical University named after N.N. Burdenko271220241321401401604202423042024Copyright © 2024, Khmyz I.S., Zolotarev O.V.2024<p>The prospective study included patients with cardiembolic stroke in the carotid (94%) and vertebrobasilar (6%) basins. Among them, men - 46% (average age 64.552.56 years), women 54% (average age 6.461.68 years). According to the NIHSS scale, 44% of the subjects had mild, 42% had moderate and 14% had severe neurological symptoms. All patients had arterial hypertension; 80% had chronic heart failure (CHF); 24% had diabetes mellitus (DM). The main group - 42 patients took anticoagulants as a secondary prophylaxis, 8 patients the control group used antiplatelet agents or completely abandoned therapy. The risks of recurrent cardioembolic stroke (PCI) were assessed on the CHA2DS2-VASc scale. During the prospective follow-up during the year, PKI developed in 11 patients. Of these, there were 5 cases in the main and 6 in the control groups. The most significant factors of PCI in the main group were atrial fibrillation, diabetes mellitus and higher NIHSS scores. The degree of patient compliance also played an important role in the results of secondary prevention.</p>cardioembolic ischemic strokesecondary preventionanticoagulantsкардиоэмболический инсультвторичная профилактикаантикоагулянты1.Камчатнов П.Р., Осмаева З.Х., Чугунов А.В. Профилактика кардиоэмболического инсульта// ConsiliumMedicum. 2020. – с. 102-105.2.Клочихина О.А., Стаховская Л.В., Полунина Е.А. и др. Эпидемиология и прогноз уровня заболеваемости и смертности от инсульта в разных возрастных группах по данным территориально-популяционного регистра// Журнал неврологии и психиатрии им. С.С. Корсакова. 2019. – с. 5–12.